APH vs VXRT · P/E 40, rev $23.09B vs rev $28.7M
Amphenol Corporation (APH) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the APH and VXRT stock pages for the full models.
Not investment advice.